Publications by authors named "Yogesh Patel"

Background: India accounts for two-thirds of the malaria burden in Southeast Asia. We described the lab-confirmed malaria cases under the Integrated Disease Surveillance Programme in Chhattisgarh, India, from 2015 to 2023.

Methods: We conducted a surveillance data analysis by abstracting the lab-confirmed malaria cases from five regions of Chhattisgarh from January 2015 to December 2023.

View Article and Find Full Text PDF

Odontogenic maxillary sinusitis (OMS) is a condition presenting to both the dental and otolaryngologic practitioner. Common causes of OMS include dental implants, displacement of a maxillary tooth root tip during extraction, migration of materials used in root canal therapy or graft material in sinus lift procedure. A 68-year-old male patient presented with complaints of repeated episodes of sinusitis for about 3 months which was not responding to conservative management.

View Article and Find Full Text PDF

Duchenne muscular dystrophy (DMD) is characterized by progressive, irreversible muscle damage that usually leads to premature death from cardiac or respiratory failure. Eteplirsen is a phosphorodiamidate morpholino oligomer and the first antisense oligonucleotide (ASO) approved for the treatment of patients with exon 51 skip-amenable DMD. This analysis presents the first population pharmacokinetics (PK) modeling and simulation performed for the ASO drug class in DMD.

View Article and Find Full Text PDF

Background: We report on TB treatment coverage and outcomes by sex among a nationally representative sample of deaths in the background of the national framework for a gender-responsive approach to TB adopted by India.

Methods: Detailed interviews were undertaken for a nationally representative sample of deaths of all ages between 2019 and 2022 from the adult most knowledgeable about the deceased. Details about TB treatment were documented for females and males for whom history of TB diagnosis ever.

View Article and Find Full Text PDF

Background Tuberculosis (TB) continues to pose a serious threat to the public health system in India. Although the National Tuberculosis Elimination Program (NTEP) is providing a wide range of interventions from early diagnosis to complete treatment to reduce morbidity and mortality from TB, adverse drug reactions (ADR) remain a challenge in treatment adherence and completion. Methods An observational cross-sectional study was conducted in selected districts of Gujarat state.

View Article and Find Full Text PDF

Background: Tubercular affection of talus in children is considered extremely rare with literature limited to few case reports. This study reports five cases of tubercular infection of talus in children and traces the various presentations and the treatment outcome. MethodsThe series describes five children with biopsy proven affection of tuberculosis of talus.

View Article and Find Full Text PDF

Ravulizumab is a second-generation complement component 5 (C5) inhibitor (C5i) approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) following positive results from two pivotal trials in patients with PNH originally naive to C5i treatment and eculizumab-experienced patients with PNH. In both trials, after the 26week primary evaluation period, all patients received ravulizumab for up to 6 years. To report ravulizumab treatment outcomes in patients with PNH originally naive to C5i treatment and eculizumab-experienced patients with PNH treated for up to 6 years.

View Article and Find Full Text PDF

The post birth revelation of child with physical anomaly taxes maternal hopes of a healthy child. However, unlike many other congenital anomalies, the Ponseti method has enabled an early and effective treatment of the clubfoot deformity. Our study aimed to assess the quality of life (QoL) of mothers with child born with idiopathic clubfoot through various stages of its management compared to a healthy infant.

View Article and Find Full Text PDF

Complement C5 inhibitor treatment with ravulizumab or eculizumab for paroxysmal nocturnal hemoglobinuria (PNH) improves outcomes and survival. Some patients remain anemic due to clinically significant extravascular hemolysis (cs-EVH; hemoglobin [Hb] ≤9.5 g/dL and absolute reticulocyte count [ARC] ≥120 × 109/L).

View Article and Find Full Text PDF

Background: The study aimed to quantify and correlate kinematic coupling linkage of foot abduction (correction of adduction) and inversion, heel varus and ankle equinus for clubfeet corrected by Ponseti technique.

Methods: Measurements of foot abduction (derotation of carpopedal block), heel varus and ankle equinus were available from Dimeglio scores in 25 feet. Radiological angles were considered for foot inversion-eversion.

View Article and Find Full Text PDF
Article Synopsis
  • Eteplirsen, golodirsen, and casimersen are drugs approved for treating Duchenne muscular dystrophy (DMD) that target specific genetic mutations associated with the disease through a mechanism called exon skipping.
  • In studies, these drugs showed similar metabolism and pharmacokinetic properties across various animal models, with consistent plasma exposure and low plasma protein binding.
  • The research suggests that these PMOs share key characteristics that could support the development of a broader PMO drug class, potentially leading to new treatments for genetic conditions like DMD.
View Article and Find Full Text PDF
Article Synopsis
  • Pregnant women with COVID-19 are at higher risk for severe outcomes, and this study evaluated the safety and effectiveness of the monoclonal antibody treatment CAS+IMD in this population.* -
  • The study, which involved 82 pregnant participants, found that CAS+IMD was well tolerated with minimal adverse reactions, and it effectively reduced viral loads without significantly affecting fetal development.* -
  • Overall, the treatment showed promising safety and efficacy, suggesting it could be a viable option for managing COVID-19 in pregnant women, although conclusions about its effects are limited due to a small number of placebo recipients.*
View Article and Find Full Text PDF

Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic blood disorder. Symptoms such as fatigue can have a substantial impact on patients' physical activity levels, sleep, quality of life, and work productivity. Ravulizumab treatment can reduce thrombosis risk, improve survival and quality of life, and reduce fatigue in PNH, but information is limited on how it impacts sleep and physical activity.

View Article and Find Full Text PDF

Background: Investigations of pain and physiologic responses response during Ponseti casting are in the preliminary stage. This short-term study aims to quantify pain responses and to note the variations, if any, during subsequent casting sessions.

Methods: In this prospective study, the pain parameters were evaluated in 34 clubfeet.

View Article and Find Full Text PDF

Tuberculosis (TB) treatment is more challenging for patients with silicosis, as it complicates the diagnosis of both diseases and increases mortality risk. Silicosis, an incurable occupational disease, confounds the diagnosis of TB and vice versa, making it more difficult to accurately identify and treat either condition. Moreover, TB appears to accelerate the progression of silicosis.

View Article and Find Full Text PDF
Article Synopsis
  • Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder that can lead to severe complications like blood clots, kidney failure, and increased mortality due to uncontrolled activity of the immune system.
  • A study analyzed data from patients in the Korean National PNH Registry to evaluate how certain factors, especially lactate dehydrogenase (LDH) and hemoglobin levels, impact risks of complications and death in those not treated with complement inhibitors.
  • Results showed that high LDH levels and male sex increased the risk of thrombosis, while low hemoglobin did not predict serious outcomes; thus, managing hemolysis in PNH patients could enhance their health results.
View Article and Find Full Text PDF
Article Synopsis
  • * Data from 505 patients showed that the after-hours group experienced higher rates of pre-existing conditions like acute cholecystitis and longer operative times but did not have an increased rate of complications compared to those treated during business hours.
  • * Both groups achieved a high success rate in critical procedures with no mortalities reported, and after-hours procedures resulted in shorter outpatient stays and fewer conversions to other surgical methods.
View Article and Find Full Text PDF

Introduction: Dermatological manifestations are common manifestations of human immunodeficiency virus (HIV) disease, seen in 80% to 95% of HIV-infected patients. Dermatological manifestations are considered clinical indicators to predict and assess the underlying immune status.

Aim: This study aims to document the dermatological manifestations in relation to CD4 count in people living with HIV (PLHIV).

View Article and Find Full Text PDF

We retrospectively studied the effect of certain characteristics of the insertion technique and the construct of tension band plates on its angular correction rates. The study included 68 physes in 28 children. The following preoperative radiological parameters were measured: interscrew angle; the length of the epiphyseal screw, its distance and angle (screw trajectory angle) with respect to the physis.

View Article and Find Full Text PDF

Introduction: The private sector plays an important role in tuberculosis (TB) elimination by providing access to quality TB care services like diagnosis and treatment, advocacy for preventive measures, innovation to address challenges in TB elimination, vaccines etc. The study aims to understand the perspectives of private practitioners on patients' TB care cascade to reinforce existing interventions by assuring the quality of care to TB patients.

Methods: The study utilized a qualitative design through in-depth interviews of private practitioners and was conducted in Ranchi and Purbi Singhbhum District of Jharkhand State from March-August 2021.

View Article and Find Full Text PDF

Introduction: India has a significant TB burden, and ongoing attempts are being made to eradicate the disease. Globally, the number of TB deaths is declining, but not quickly enough to meet the End TB Goals. The National Strategic Plan (NSP) 2017-2025 in India set in motion an ambitious effort to expand the scope and efficacy of the National Tuberculosis Elimination Program (NTEP).

View Article and Find Full Text PDF

Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by uncontrolled terminal complement activation leading to intravascular hemolysis (IVH), thrombosis, and impairments in quality of life (QoL). The aim of this study was to identify the clinical drivers of improvement in patient-reported outcomes (PROs) in patients with PNH receiving the complement component 5 (C5) inhibitors eculizumab and ravulizumab.This post hoc analysis assessed clinical outcomes and PROs from 246 complement inhibitor-naive patients with PNH enrolled in a phase 3 randomized non-inferiority study that compared the C5 inhibitors ravulizumab and eculizumab (study 301; NCT02946463).

View Article and Find Full Text PDF

We studied whether the two-plate tension band configuration is more prone for intraarticular deformations than the single plate application used for coronal plane deformities (CPD). The study was based on radiological chart review (retrospective cross-sectional) of records of children [15 patients (30 plates) with limb length discrepancies (LLD) and 20 patients (36 plates) with CPD]. Interscrew angle, slope angle, and roof angle were compared in the initial postoperative and final radiographs to determine changes of tibial morphology.

View Article and Find Full Text PDF

Background: Achieving the target for eliminating tuberculosis (TB) in India by 2025, 5 years ahead of the global target, critically depends on strengthening the capacity of human resources as one of the key components of the health system. Due to the rapid updates of standards and protocols, the human resources for TB health care suffer from a lack of understanding of recent updates and acquiring necessary knowledge.

Objective: Despite an increasing focus on the digital revolution in health care, there is no such platform available to deliver the key updates in national TB control programs with easy access.

View Article and Find Full Text PDF